Empagliflozin
Empagliflozin

4.68
A generic medicine indicated for blood pressure and heart conditions and diabetes. Assists in glucose excretion through the kidneys and supports renal function.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Empagliflozin
Reference Brand
Jardiance
Product Origin
Generic Product
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Antidiabetics, Diabetes Management
Product Category
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor
Pharmacological Class
SGLT2 Inhibitor
Manufacturer Description
Intended to relieve elevated blood sugar to support glycemic stability and target renal glucose clearance.
Mechanism of Action
Blocks SGLT2 in renal proximal tubules, lowering glucose reabsorption so that excess blood sugar is lost through urination.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
24 hours
Contraindications
Severe renal impairment (for glycemic control), Diabetic ketoacidosis
Severe Adverse Events
Fournier's gangrene — requires immediate medical attention, Diabetic ketoacidosis — requires immediate medical attention
Common Side Effects
Increased urination, Nausea
Uncommon Side Effects
Urinary tract infection, Genital fungal infection, Dyslipidemia
Drug Interactions
Insulin, Diuretics
Pregnancy Safety Warnings
TGA Category C: Avoid during second and third trimesters. Breastfeeding: Not recommended.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Empagliflozin is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to buy Blood Clot Prevention Medication - Xarelto Australia